Medify Solutions Limited - Announces Results of Strategic Commercial Model Review

Toronto (ots/PRNewswire) - Over the past month, Medify Solutions
Limited (OTC: MFYS) has conducted a full and extensive review of its
commercial model being operated and going forward in the UK, European
and global markets. This exercise has examined the various options
that exist in the market, with the prime focus of adopting the one
which shows the greatest potential for rapid revenue growth and
enhancement of the shareholder value in Medify Solutions.

The fundamental approaches that result from this exercise, include
one of Medify Solutions always (directly or indirectly) owning the
installed customer that is utilising a Medify solution.

Based on a licensing agreement sales model at a minimum order
quantity of 5 and reoccurring revenues with a minimum contractual
period of 24 months. The headline financial results show a projected
income model with a gross profit margin of around 78%, with a
licensing model showing positive cash flow per user in approximately
three months from install.

The revised Medify model, in simple terms, means that every 1% of
UK market penetration equates to USD$5.1million of income, with a
Gross Profit margin of USD$3.9million per annum.

CEO Ian O'Reilly, commenting on the work stated, "This activity
has been a valuable exercise and revisited the commercial
fundamentals of the Medify product suite. It is very encouraging to
see an updating of the business model showing sustainable revenue and
greater profitability opportunities. This is one of the core basics
in support of a planned aggressive marketing campaign in a Q4
timeframe."

Contact: press@medifysolutions.com

Company website: www.medifysolutions.com

This news release contains forward-looking statements that are
subject to certain risks and uncertainties that may cause actual
results to differ materially from those projected on the basis of
such forward-looking statements. The words "estimate," "project,"
"intends," "expects," "believes," and similar expressions are
intended to identify forward-looking statements. Such forward-looking
statements are made based on management's beliefs, as well as
assumptions made by, and information currently available to,
management pursuant to the "safe-harbour" provisions of the Private
Securities Litigation Reform Act of 1995. For a more complete
description of these and other risk factors that may affect the
future performance of Medify Solutions Limited, see "Risk Factors" in
the Company's Annual Report on Form 10-KSB and its other filings with
the Securities and Exchange Commission. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak
only as of the date made and the Company undertakes no obligation to
disclose any revision to these forward-looking statements to reflect
events or circumstances after the date made or to reflect the
occurrence of unanticipated events.

Company website: www.medifysolutions.com

ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Contact: press@medifysolutions.com